The Lancet. Neurology (Lancet Neurol)

Journal PubWeight™ 3421.26‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. 2008 21.53
2 Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. 2010 19.42
3 Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. 2007 18.62
4 The spectrum of neuromyelitis optica. 2007 11.83
5 Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. 2013 11.47
6 Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. 2011 10.82
7 Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. 2006 9.99
8 Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. 2013 9.43
9 Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. 2009 9.40
10 Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. 2008 9.02
11 Revising the definition of Alzheimer's disease: a new lexicon. 2010 8.74
12 Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. 2009 8.42
13 The projected effect of risk factor reduction on Alzheimer's disease prevalence. 2011 8.15
14 Epidemiology of Parkinson's disease. 2006 8.13
15 Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. 2010 7.97
16 Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data. 2006 7.32
17 Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. 2003 7.05
18 Risk of dementia in diabetes mellitus: a systematic review. 2006 6.97
19 Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. 2009 6.90
20 Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. 2008 6.76
21 Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. 2007 6.62
22 Preventing stroke: saving lives around the world. 2007 6.55
23 Neurobehavioural effects of developmental toxicity. 2014 6.27
24 Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. 2013 6.18
25 Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. 2007 6.15
26 CSF markers for incipient Alzheimer's disease. 2003 6.12
27 Mechanisms of brain injury after intracerebral haemorrhage. 2006 6.06
28 Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. 2008 6.06
29 Cerebral microbleeds: a guide to detection and interpretation. 2009 6.02
30 Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. 2009 6.02
31 MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. 2012 5.91
32 Moderate and severe traumatic brain injury in adults. 2008 5.82
33 Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. 2010 5.79
34 An active and socially integrated lifestyle in late life might protect against dementia. 2004 5.78
35 Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. 2010 5.76
36 Silent brain infarcts: a systematic review. 2007 5.76
37 Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. 2009 5.75
38 Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. 2013 5.73
39 Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. 2014 5.61
40 Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. 2011 5.60
41 Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. 2015 5.57
42 CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study. 2015 5.50
43 Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. 2007 5.46
44 Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. 2008 5.40
45 Non-motor symptoms of Parkinson's disease: diagnosis and management. 2006 5.40
46 Neurocysticercosis: updated concepts about an old disease. 2005 5.37
47 Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. 2009 5.35
48 TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. 2008 5.33
49 Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. 2010 5.23
50 Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. 2012 5.18
Next 50